Overcoming the Barriers to the Development of Medicines for Ultra Rare Diseases
In the third and final article in the series on Orphan Drugs, Bryan Hurst discusses how to overcome the barriers to the development of medicines for the treatment of ultra-rare diseases. To read the first article on orphan drugs, click here, and for the second article, click here. The decision to invest in developing a […]
